Nitric oxide synthase (NOS) oxidizes one of the two equivalent terminal guanidino nitrogens of L-arginine using NADPH and oxygen as substrates, as well as flavin adenine dinucleotide, flavin mononucleotide, tetrahydrobiopterin and haem as cofactors to produce L-citrulline and the biologically active free radical nitric oxide (NO). [1] [2] [3] In general, NOS has been divided into two major sub-enzymes, i.e. a constitutive NOS (cNOS) which requires Ca 2ϩ /Calmodulin for its activation, and an inducible NOS (iNOS) which is independent of Ca 2ϩ /Calmodulin for its activation. In addition, cNOS has further been divided into neuronal NOS (nNOS) found mainly in the brain, and endothelial NOS (eNOS) predominantly present in the vascular endothelium. It has been reported that nNOS generates NO that functions as a neurotransmitter regulating neuronal transmission, 4) and that eNOS generates low concentration of NO which lowers blood pressure.
/Calmodulin for its activation, and an inducible NOS (iNOS) which is independent of Ca 2ϩ /Calmodulin for its activation. In addition, cNOS has further been divided into neuronal NOS (nNOS) found mainly in the brain, and endothelial NOS (eNOS) predominantly present in the vascular endothelium. It has been reported that nNOS generates NO that functions as a neurotransmitter regulating neuronal transmission, 4) and that eNOS generates low concentration of NO which lowers blood pressure. 5) On the other hand, iNOS, which is expressed in activated macrophage in response to inflammatory cytokines and lipopolysaccharides (LPS), generates NO that has cytotoxic/cytostatic activity against intracellular pathogens including viruses and therefore plays an important role as host defense mediator. 6) However, excessive production of NO by iNOS has been involved in numerous disease states such as septic shock, 7) rheumatoid arthritis, 8) hypotension, 9) chronic ileitis 10) and autoimmune diabetes.
11)
There was a main approach that could potentially be exploited to inhibit excessive production of NO, and analogues of L-arginine, L-lysine, L-ornithine, L-citrulline and guanidine such as N G -methyl-L-arginine, 12 ) N G -nitro-L-arginine, 13 ) N G -nitro-L-arginine methylester (L-NAME), 14 ) N 6 -(1-iminoethyl)-L-lysine, 15 ) N 5 -(1-iminoethyl)-L-ornithine, 16 ) L-thiocitrulline, 17) S-alkyl-L-thiocitrulline 18) and aminoguanidine 19) have been synthesized and investigated in connection with a number of inflammatory diseases. However, these analogues have not been approved for the treatment of inflammatory diseases due to their undesired inhibition of cNOS. In addition to the L-amino acid analogues described above, a number of non-amino acid NOS inhibitors have been investigated. [20] [21] [22] [23] [24] [25] [26] [27] [28] Recently, we reported that the 2-imino-1,3-oxazolidine (1a) (Chart 1) weakly inhibits iNOS and that introduction of an alkyl moiety on its oxazolidine ring enhances the inhibitory activity and selectivity for iNOS (1b, Chart 1, Table 2 ). 29) In our search for better iNOS inhibitors, we focused our efforts on the 2-aminothiazole scaffold 3 as it possesses a ring similar to that of 1a. Although the 4,5-di- methylthiazol-2-ylamine (2) has previously been reported to inhibit iNOS 20) to our knowledge, derivatives of 2-aminothiazole scaffold have hardly been studied in connection with iNOS inhibition. Herein, we report the synthesis and structure-activity relationships (SARs) for NOS inhibition of a series of 2-aminothiazole derivatives.
Chemistry
As illustrated in Chart 2, annulation of ketone 4a-g with thiourea using I 2 led to a mixture of the 2-aminothiazole regio isomers 5 and 6, which were separated by column chromatography with except for 6d ( Table 1) .
Next, as shown in Chart 3, the 2,4,5-trisubstituted-2-aminothiazole derivatives were synthesized. Reaction of achlorocyclopentanone with phenylthiourea and that of 5a with isopropylisothiocyanate easily gave the 2-phenylamino derivative 7 and the thiourea derivative 8, respectively.
30)

Results and Discussion
The inhibitory activity of the synthesized compounds (5a-g, 6a-c, g, 7, 8) against iNOS and nNOS was evaluated according to previously reported procedures 31, 32) with some modifications and their selectivity was determined from nNOS IC 50 value/iNOS IC 50 value ratio.
As shown in Table 2 , when a methyl and an isopropyl groups were inserted into the 4-position and 5-position of the 2-aminothiazole ring, respectively, the inhibitory activity against iNOS was improved and the selectivity for iNOS over nNOS was greatly increased (5a: IC 50 ϭ0.6 mM, 4.7-fold stronger than that of 2; nNOS/iNOSϭ23, selectivity of 5a for iNOS 26-fold higher than that of 2). An additional insertion of a methyl group into the isopropyl group of 5a significantly decreased nNOS inhibition, thus the selectivity of 5b for iNOS was the highest among the synthesized compounds (5b: nNOS IC 50 value of 100 mM, nNOS/iNOSϭ33, selectivity of 5b for iNOS 37-fold higher than that of 2). When the length of side chain at the 5-position of the thiazole ring increased, the inhibitory activity against iNOS decreased and that against nNOS was completely abolished (5c: iNOS IC 50 
7.9 34 4.3 1b 29) 0.041 0.92 22
L-NAME 300 0.8 0.0027 a) IC 50 values for iNOS and nNOS were determined by testing each compound at eight concentrations. b) iNOS and nNOS activity was evaluated according to previously reported methods with some modifications. 31, 32) c) Selectivity was defined as the ratio of IC 50 value of nNOS to iNOS. d) n.s.ϭno significant effect (Ͻ5% inhibition). e) Not determined. f) Not tested.
value of 54 mM; nNOS IC 50 value of n.s. @100 mM). Therefore, it is suggested that an increase of the length of side chain at the 5-position can be tolerated in iNOS inhibition but not in nNOS. Monosubstituted compounds, on the other hand, generally displayed moderate inhibitory activity against both iNOS and nNOS (6a-c). Unexpectedly, the inhibitory activity against iNOS of 5d, a thiazole analogue of 1b, was much weaker than that of 1b. Therefore, it is suggested that a structurally planar ring is not favorable for strong iNOS inhibition. 21) Next, we evaluated the inhibitory activity of other 2-aminothiazole derivatives against NOS.
The inhibitory activity of the bicyclic compounds (5e, f) against iNOS were similar to that of 2. On the other hand, introduction of substituent at the 2-amino group (7, 8) abolished the inhibitory activity against both iNOS and nNOS. These findings suggest that strong iNOS inhibition requires a non-substituted 2-amino group on the thiazole ring. Hydrophilically substituted 2-aminothiazole derivatives (5g, 6g) also displayed no significant inhibition against both iNOS and nNOS. As iNOS oxygenase haem domain has been reported to form a hydrophobic pocket, 33) the contrastive hydrophilicity of 5g and 6g is assumed to be responsible for the abolishment of inhibitory activity against iNOS.
Conclusion
In this study, we evaluated the inhibitory activity of a series of 2-aminothiazole derivatives against both iNOS and nNOS. Our results show that introduction of appropriatelysized substituent at the 4-and 5-position of the 2-aminothiazole ring improves the inhibitory activity and selectivity for iNOS. We also found that the selectivity of 5a and 5b for iNOS was similar to that of oxazolidine 1b and much higher than that of L-NAME. However, we could not enhance the inhibitory activity against iNOS by introducing an alkyl substituent into the 2-aminothiazole ring as we could in the case of oxazolidine one. On the other hand, introduction of bulky or hydrophilic substituent at any position of the 2-aminothiazole ring remarkably decreased or even abolished the inhibitory activity against NOS.
Experimental
General Melting points were recorded on a Yanagimoto micro-melting point apparatus MP-J3 without correction.
1 H-NMR spectra were determined in the indicated solvent on a Varian Jemini (200 MHz) or a JEOL JNM-LA300 (300 MHz) spectrometer. Chemical shifts are expressed as d (ppm) values downfield from tetramethylsilane as an internal standard. Splitting patterns are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (mutiplet), and br (broad). Coupling constants are given in hertz. EI-MS were recorded on a JEOL JMS D-300 or a Hitachi M-80-B mass spectrometer. Column chromatography was carried out on Kieselgel 60 (Merck; 70-230 mesh).
General Procedure for Synthesis of 2-Aminothiazole Derivatives A mixture of ketone 4 (46 mmol), thiourea (93 mmol), and I 2 (46 mmol) was heated at 100°C with vigorous stirring for 8 h. To this reaction mixture was added hot water (100 ml) and charcoal (5 g). After stirring for 15 min, the charcoal was filtered off and to the filtrate was added 28% aqueous ammonia solution (50 ml). Extraction with two 50-ml portions of ether followed by drying of the combined organic extracts with MgSO 4 , and evaporation under reduced pressure gave a mixture of 5 and 6. The mixture was purified by column chromatography on silica gel using MeOH/CHCl 3 (1/100) as eluent to give a free amine, or as hydrochloride salt by treatment with ethanolic 4 N hydrochloric acid solution.
The following 2-aminothiazole derivatives (5a-g, 6a-c, g) were synthesized from the corresponding starting materials (4a-g) according to the general procedure. 31) RAW 264.7 macrophage cells were grown in Dulbecco's modified eagles medium supplemented by 10% fetal bovine serum under 5% CO 2 atmosphere at 37°C. To this medium were added lipopolysaccharide and interferon-g to make a final concentration of 0.2 mg/ml and 100 unit/ml respec-tively. The grown cells were then collected and mixed with Tris and dithiothreitol to make a final concentration of 50 mM and 100 mM respectively at pH 7.5. The mixture was centrifuged at 10000ϫg for 30 min, and the supernatant was added to Dowex HCR-W2 at 4°C and stirred for 30 min at the same temperature. This solution was used as crude enzyme. NOS activity was measured by monitoring the conversion level of L-citrulline from L-arginine. To 70 ml of the crude enzyme solution was added, 20 ml of Tris (pH 7.5) including 1 mM of NADPH, 10 ml of test-compound, 20 ml of 10 mCi/ml
4-Methyl-5-(1-methyl)ethylthiazol-2-ylamine (5a) and 4-(2-Methyl)-propylthiazol-2-ylamine (6a) from 4-Methyl
]-arginine and 80 ml of Tris (pH 7.5). The resulting mixture was incubated at 37°C for 30 min, after which 20 ml of 0.1 M (pH 5.0) including 2 mM ethylenediamine-N,N,NЈ,NЈ-tetraacetic acid (EDTA) and 2 mM O,OЈ-bis(2-aminoethyl)ethyleneglycol-N,N,NЈ,NЈ-tetraacetic acid (EGTA) were added. To the resulting solution was added Dowex 50W-8X, and the whole was stirred for 30 min. L- [H 3 ]-Citrulline in the supernatant was evaluated by scintillation counting.
Preparation of Partially Purified nNOS Enzyme and Determination of Inhibitory Activity against nNOS 32) Male wistar rat (150-170 g) cerebella were homogenized in 50 mM of N-2-hydroxyethylpiperazine-NЈ-2-ethanesulufonic acid (pH 7.1) including 0.1 mM phenylmethylsulfonyl fluoride, 12.5 mM 2-mercaptoethanol and 0.5 mM EDTA, and centrifuged at 10000ϫg for 1 h. To the supernatant was added Dowex HCR-W2 and the resulting mixture was stirred for 30 min at 4°C. The final supernatant was used as crude enzyme. NOS activity was measured by monitoring the conversion level of L-citrulline from L-arginine. To 100 ml of the crude enzyme solution was added 60 ml of 50 mM Tris (pH 7.5) including 1 mM NADPH, 2 mM CaCl 2 and 300 nM calmodulin, 10 ml of test-compound, 20 ml of 10 mCi/ml L- [H 3 ]-arginine and 10 ml of Tris (pH 7.5). The resulting mixture was incubated at 37°C for 30 min, after which 200 ml of 0.1 M sodium acetate buffer (pH 5.0) including 2 mM EDTA and 2 mM EGTA were added. To the resulting solution was added Dowex 50W-8X, and the whole was stirred for 30 min. L- [H 3 ]-Citrulline in the supernatant was evaluated by scintillation counting.
